{'fraction_non_alphanumeric': 0.03090507726269316, 'fraction_numerical': 0.024282560706401765, 'mean_word_length': 5.135135135135135, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Gln → Arg 191 Polymorphism of Paraoxonase and Parkinson’s Disease

We investigated the Gln → Arg 191 polymorphism in paraoxonase (PON1) in St. Petersburg population, in three clinically differentiated groups of patients with Parkinson’s disease (PD) and in the symptomatic tremor group. A new approach for Gln → Arg 191 PON1 polymorphism genotyping is suggested. No significant differences in the groups studies as compared to the controls was observed.